Cambridge Investment Research Advisors
AGYS icon

Cambridge Investment Research Advisors’s Agilysys AGYS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio AGYS Stock Details AGYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,511
Closed -$298K – 3927
2025
Q4 		$298K Buy
+2,511
New +$302K ﹤0.01% 3212
2025
Q1 		– Sell
-2,871
Closed -$378K – 3502
2024
Q4 		$378K Buy
+2,871
New +$352K ﹤0.01% 2649
2024
Q2 		– Sell
-4,755
Closed -$401K – 3315
2024
Q1 		$401K Buy
+4,755
New +$384K ﹤0.01% 2466

Other funds holding AGYS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Cambridge Investment Research Advisors's AGYS Position: Q1 2026 in Review

Cambridge Investment Research Advisors sold out of Agilysys (AGYS) in Q1 2026, closing a stake of 2,511 shares — an estimated $298K sold.

Cambridge Investment Research Advisors first reported a position in AGYS in Q1 2024 and held it in 3 quarters. The position peaked at $401K in Q1 2024. 252 funds tracked by Wall St. Rank hold AGYS as of Q1 2026.

  • Cambridge Investment Research Advisors reported no remaining Agilysys position as of Q1 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 2,511 Agilysys shares in Q1 2026, an estimated $298K.
  • Cambridge Investment Research Advisors first reported a position in Agilysys in Q1 2024 and held it in 3 quarters.
  • Cambridge Investment Research Advisors's Agilysys position peaked at $401K in Q1 2024.
  • 252 funds tracked by Wall St. Rank held Agilysys as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.